Ocuphire Pharma Inc (OCUP)

Ocuphire Pharma Inc Azioni (OCUP) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1.18% 1.711	1.691	11.94	3.674	1.749
Operating Expenses	32.29% 9.419	7.12	5.549	9.063	7.88
Benefits Costs and Expenses	35.90% 8.817	6.488	6.36	8.635	7.54
Costs And Expenses	35.90% 8.817	6.488	6.36	8.635	7.54
Operating Income/Loss	41.98% -7.708	-5.429	6.386	-5.389	-6.131
Income/Loss From Continuing Operations Before Tax	48.13% -7.106	-4.797	5.575	-4.961	-5.791
Income Tax Expense/Benefit	100.00% -	-0.002	0.014	-	-
Income/Loss From Continuing Operations After Tax	48.20% -7.106	-4.795	5.561	-4.961	-5.791
Net Income/Loss	48.20% -7.106	-4.795	5.561	-4.961	-5.791
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,088% 24.52	0.4726	21.45	20.96	20.94
Diluted Average Shares	5,088% 24.52	0.4726	22.41	20.96	20.94
Basic Earnings Per Share	38.10% -0.29	-0.21	0.26	-0.24	-0.28
Diluted Earnings Per Share	38.10% -0.29	-0.21	0.25	-0.24	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-